Because FAK inhibitors reduced rheumatoid synovial fibroblast invasion and migration, which are two important components of rheumatoid arthritis progression, we evaluated whether FAK protein itself contributes to synovial fibroblast invasion and arthritis severity. Here, PTK2 is linked to arthritic joint disease.